Abstract
The long-term evolution of Hu antibody (Hu-Ab) titers in patients with paraneoplastic neurologic syndromes (PNSs) is not known. Described is the evolution of Hu-Ab titers in 35 patients with PNS with a median follow-up of 32 months (range 6 to 108 months). No correlation was observed between Hu-Ab titers and neurologic outcome, tumor evolution, or type of treatment. Serial Hu-Ab determinations are not useful for monitoring the clinical outcome of patients with PNS.
Original language | English |
---|---|
Pages (from-to) | 1947-1949 |
Number of pages | 3 |
Journal | Neurology |
Volume | 63 |
Issue number | 10 |
Publication status | Published - Nov 23 2004 |
ASJC Scopus subject areas
- Neuroscience(all)